GPhA Web site | Generic Pharmaceutical Association

Generics Spotlight
Events

07.27.10 - GPhA: FTC Position Misguided on Consumer Benefits of Patent Litigation Settlements

07.26.10 - Generic Medicines Saved U.S. Health Care System $139.6 Billion in 2009; $824 Billion Saved over the Last Decade

07.21.10 - GPhA Says New Study Makes Compelling Case for Increasing Generic Drug Utilization in Medicaid Program

07.16.10 - GPhA Says Senate Increase in FDA Funding is “Step in the Right Direction”

07.02.10 - GPhA Warns that House-Passed Curb on Settlements Will Delay Access to Affordable Medicines

10.19.10 - GPhA/FDA 2010 Fall Technical Conference

12.08.10 - 13th Annual IGPA Conference

In Congress

Find out how GPhA is working with Congress on increasing consumer access to safe, effective and affordable generic medicines.

Regulatory/Science

Generic medicines must meet strict FDA guidelines for approval. Learn more about regulatory and scientific issues facing the generic pharmaceutical industry and FDA.

States

Increasingly, state lawmakers are dealing with issues that impact consumers’ ability to obtain generic medicines. Learn more about what’s happening in state capitols.